Skip to main content

Advertisement

Log in

The H-cadherin (CDH13) gene is inactivated in human lung cancer

  • Original investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

We have previously reported frequent allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer. Since the H-cadherin (CDH13) gene has been isolated and mapped to this common region of allelic loss, we have investigated this gene in human lung cancer. The reverse transcription/polymerase chain reaction technique has revealed the loss of expression in four (57%) of seven lung cancer cell lines. To study the CDH13 gene further, we have analyzed deletions, genetic alterations, and methylation status at the 5’ region of this gene. Three (75%) of four cell lines that have lost expression show a deletion of the CDH13 locus accompanied by hypermethylation of the remaining allele. Moreover, hypermethylation has been observed in nine (45%) of 20 primary lung cancers. These results suggest that a combination of deletion and hypermethylation causes inactivation of the CDH13 gene in a considerable number of human lung cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 27 January 1998 / Accepted: 28 March 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sato, M., Mori, Y., Sakurada, A. et al. The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet 103, 96–101 (1998). https://doi.org/10.1007/s004390050790

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004390050790

Keywords

Navigation